TREM2 and cancer: Supporting the clinical significance of myeloid cells within the TME, we previously demonstrated that depletion of immunosuppressive MDSCs significantly reduces tumor growth and pulmonary metastasis in syngeneic mouse models.5 Furthermore, TREM2 regulates the expression of anti-inflammatory genes and antagonizes the pro-inflammatory responses which may be relevant in cancer development and progression.